本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的补充材料
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (6788)
All Articles published online
|
Publishing Process of This Article
|
Sep 27, 2022 (publication date) through Apr 28, 2025
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Haider MB, Al Sbihi A, Chaudhary AJ, Haider SM, Edhi AI. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study. World J Hepatol 2022; 14(9): 1804-1816 [PMID: 36185720 DOI: 10.4254/wjh.v14.i9.1804] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v14/i9/1804.htm |
| 编号 | Citing Articles |
| 1 |
Ahmad Alzamami, Eman M. Radwan, Eman Abo-Elabass, Mohammed El Behery, Hussah Abdullah Alshwyeh, Ebtesam Al-Olayan, Abdulmalik S. Altamimi, Nashwah G. M. Attallah, Najla Altwaijry, Mariusz Jaremko, Essa M. Saied. Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization. BMC Chemistry 2023; 17(1) doi: 10.1186/s13065-023-01063-5
|
| 2 |
Philipp Heumann, Andreas Albert, Karsten Gülow, Deniz Tümen, Martina Müller, Arne Kandulski. Insights in Molecular Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(10): 1831 doi: 10.3390/cancers16101831
|
| 3 |
Ali Jawad Akki, Srinivas Nanduri, Shankargouda V Patil, Kusal K Das, Prachi Parvatikar. Exploring the microRNA-mitochondrial nexus in hepatocellular carcinoma. Mitochondrion 2025; 84: 102045 doi: 10.1016/j.mito.2025.102045
|
| 4 |
Claudia Oana Cobilinschi, Ioana Săulescu, Simona Caraiola, Andra Florina Nițu, Radu Lucian Dumitru, Ioana Husar-Sburlan, Andra Rodica Bălănescu, Daniela Opriș-Belinski. A “Mix and Match” in Hemochromatosis—A Case Report and Literature Focus on the Liver. Medicina 2023; 59(9): 1586 doi: 10.3390/medicina59091586
|
| 5 |
Zachary H. Henry, Curtis K. Argo. Management of Chronic Liver Disease in Patients with Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 135 doi: 10.1016/j.cld.2024.08.004
|
| 6 |
Mariateresa Cristani, Andrea Citarella, Federica Carnamucio, Nicola Micale. Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer. Biomolecules 2024; 14(8): 1031 doi: 10.3390/biom14081031
|
| 7 |
Chiara Marcon, Marta Medeot, Alessio Michelazzi, Valentina Simeon, Alessandra Poz, Sara Cmet, Elisabetta Fontanini, Anna Rosa Cussigh, Marianna Chiozzotto, Giovanni Barillari. TSAT-Urated Insights: Clarifying the Complexities of Hereditary Hemochromatosis and Its Guidelines. Hemato 2024; 5(4): 459 doi: 10.3390/hemato5040035
|
| 8 |
Mahmoud Aryan, Thomas Ruli, Mohamed Shoreibah. HCC in patients without cirrhosis: A review. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000224
|
| 9 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
|
| 10 |
George J. Kontoghiorghes. The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency. International Journal of Molecular Sciences 2024; 25(9): 4654 doi: 10.3390/ijms25094654
|